studi
determin
effect
chicken
egg
yolk
antibodi
igi
immun
respons
intestin
mucos
mice
infect
salmonella
typhimurium
sixti
mice
divid
group
treat
streptomycin
steril
water
day
follow
day
without
treatment
control
group
unchalleng
wherea
mice
three
group
treat
twice
cfu
ml
typhimurium
next
day
control
mice
continu
receiv
treatment
wherea
mice
remain
three
group
oral
administ
mg
ml
specif
igi
mg
ml
nonspecif
igi
pb
typhimurium
activ
gutassoci
lymphoid
tissu
increas
releas
mucosa
increas
number
activ
tlymphocyt
cytotox
specif
igi
attenu
increas
decreas
typhimurium
induc
mobil
cell
epithelium
cell
lamina
propria
reflect
inflammatori
process
attenu
igi
result
suggest
specif
igi
modul
intestin
mucos
immun
respons
typhimurium
infect
chicken
egg
yolk
antibodi
commonli
refer
immunoglobulin
igi
attract
consider
interest
altern
antibiot
control
infecti
diseas
anim
human
igi
possess
sever
advantag
mammalian
igg
costeffect
conveni
high
yield
numer
studi
demonstr
specif
igi
antibodi
highli
effect
varieti
import
intestin
pathogen
escherichia
coli
salmonella
rotavirus
coronaviru
transmiss
gastroenter
viru
epidem
diarrhea
viru
exact
mechan
igi
counteract
pathogen
activ
determin
howev
sever
mechan
propos
show
specif
igi
may
counteract
pathogen
activ
includ
inhibit
adhes
agglutin
opson
follow
phagocytosi
toxin
neutral
gut
main
site
igi
activ
intestin
pathogen
mucos
immun
system
gastrointestin
tract
gener
refer
gutassoci
lymphoid
tissu
galt
play
import
role
first
line
defens
protect
ingest
pathogen
galt
account
mucos
immun
system
distribut
throughout
intestin
either
organ
galt
ie
peyer
patch
isol
follicl
mesenter
lymph
node
diffus
galt
consist
lymphocyt
scatter
throughout
epithelium
lamina
propria
diet
modul
immunolog
function
galt
multipl
way
affect
host
resist
infect
exampl
demonstr
spray
dri
anim
plasma
immunoglobulin
present
modul
mucos
system
immun
respons
wean
rat
challeng
staphylococc
aureu
enterotoxin
b
howev
studi
examin
immunomodulatori
effect
igi
host
immun
respons
condit
associ
gutbarri
dysfunct
inflammatori
respons
present
studi
examin
effect
igi
intestin
mucos
immun
system
use
mous
model
intestin
infect
induc
salmonella
typhimurium
object
examin
effect
igi
gut
histolog
determin
effect
igi
cytokin
involv
inflammatori
respons
final
determin
effect
igi
lymphocyt
popul
galt
standard
strain
typhimurium
cvcc
obtain
nation
institut
food
drug
control
beij
china
typhimurium
grown
trypton
soya
broth
oxoid
hampshir
uk
h
cell
harvest
centrifug
g
min
wash
twice
mm
pb
solut
ph
resuspend
pb
suspens
adjust
cell
densiti
cfu
ml
use
immun
hen
challeng
infect
mice
specif
igi
typhimurium
prepar
manner
similar
previous
report
method
briefli
igi
produc
use
white
leghorn
lay
hen
immun
formaldehydekil
typhimurium
concentr
cfu
ml
aid
freund
adjuv
sigmaaldrich
st
loui
mo
igi
antibodi
subsequ
isol
egg
yolk
sever
purif
step
includ
salt
precipit
precipit
satur
ammonium
sulfat
follow
precipit
wv
sodium
sulfat
ultrafiltr
use
vivaflow
tangenti
flow
ultrafilt
vivasci
hannov
germani
kda
cutoff
membran
igi
powder
obtain
freezedri
ultrafiltr
fraction
titer
igi
determin
enzymelink
immunosorb
assay
describ
zhen
et
al
powder
igi
titer
combin
use
igi
protect
test
nonspecif
igi
obtain
addit
nonimmun
lay
hen
use
similar
method
sixti
wean
kunm
mice
equal
male
femal
ratio
weigh
g
purchas
dalian
medic
univers
laboratori
anim
centr
dalian
china
use
permiss
number
scxk
anim
allow
acclim
laboratori
facil
day
inclus
experi
hous
standard
laboratori
condit
rel
humid
h
lightdark
cycl
given
food
water
ad
libitum
experi
perform
accord
experiment
anim
manag
law
china
approv
anim
ethic
committe
dalian
medic
univers
dalian
china
mice
randomli
divid
group
anim
per
group
follow
acclim
period
week
group
suppli
ml
steril
solut
contain
gl
streptomycin
ml
steril
water
control
group
day
follow
day
without
streptomycin
fast
h
control
mice
unchalleng
wherea
mice
remain
three
group
oral
challeng
ml
typhimurium
concentr
cfu
ml
h
experi
typhimurium
challeng
mice
control
group
continu
receiv
treatment
wherea
mice
remain
group
oral
administ
ml
solut
contain
mg
ml
specif
igi
mg
ml
nonspecif
igi
pb
day
consecut
day
clinic
respons
mice
monitor
throughout
experi
term
lethargi
appet
weight
gain
surviv
rate
random
segment
jejunum
excis
fix
formalin
embed
paraffin
section
slice
stain
hematoxylin
eosin
accord
standard
procedur
stain
section
examin
microscop
pathologist
unawar
experiment
treatment
mice
subject
use
score
system
describ
tabl
excis
peyer
patch
small
intestin
cm
sampl
jejunum
wash
diethypyrocarbonatetr
water
frozen
liquid
nitrogen
homogen
homogen
subject
total
rna
extract
use
simpl
total
rna
kit
tiangen
biotech
compani
beij
china
ccord
manufactur
instruct
puriti
integr
rna
confirm
agaros
gel
electrophoresi
ratio
uv
absorb
measur
uv
spectrophotomet
beij
purkinj
gener
instrument
compani
beij
china
rna
concentr
determin
measur
absorb
nm
subsequ
ng
rna
revers
transcrib
cdna
use
rt
reagent
kit
perfect
real
time
takara
dalian
china
accord
manufactur
instruct
mrna
express
tumor
necrosi
measur
intestin
mucosa
realtim
quantit
pcr
reaction
mixtur
contain
dilut
cdna
templat
primer
premic
ex
takara
dalian
china
steril
distil
water
primer
specif
cytokin
jejun
fragment
cm
fix
formalin
dehydr
grade
seri
ethanol
embed
paraffin
wax
section
section
dewax
rehydr
wash
pb
section
immers
h
solut
room
temperatur
min
section
preincub
nonimmun
serum
min
subsequ
replac
correspond
primari
mous
monoclon
antibodi
humidifi
chamber
incub
overnight
primari
antibodi
use
antit
cell
receptor
biolegend
san
diego
ca
slice
wash
pb
incub
horseradish
peroxidas
conjug
goat
antimous
igg
antibodi
biolegend
min
local
antigen
indic
brown
color
obtain
stain
humidifi
chamber
min
room
temperatur
afterward
sampl
wash
pb
counterstain
hematoxylin
min
room
temperatur
wash
pb
seal
mount
medium
neg
control
perform
without
primari
antibodi
sampl
store
observ
microscopi
lymphocyt
intraepithelium
lamina
propria
peyer
patch
small
intestin
obtain
previous
describ
briefli
isol
lymphocyt
intestin
intraepitheli
small
intestin
remov
clean
pb
mesenteri
node
peyer
patch
care
excis
intestin
open
longitudin
cut
cm
piec
tissu
incub
medium
supplement
fetal
bovin
serum
fb
ge
healthcar
life
scienc
marlborough
mm
dithiothreitol
sigmaaldrich
st
loui
mo
mm
ethylenediaminetetraacet
acid
min
cell
suspens
filter
nylon
mesh
centrifug
g
min
pellet
purifi
use
continu
percol
gradient
ge
healthcar
life
scienc
marlborough
briefli
pellet
resuspend
vv
percol
place
vv
percol
centrifug
min
interfac
layer
remov
cell
wash
harvest
centrifug
min
isol
lymphocyt
lamina
propria
remain
tissu
digest
collagenas
ii
sigmaaldrich
st
loui
mo
min
cell
suspens
filter
nylon
mesh
centrifug
g
min
pellet
purifi
continu
percol
gradient
describ
isol
lymphocyt
peyer
patch
section
peyer
patch
cm
ground
syring
plunger
nylon
mesh
medium
supplement
vv
fb
lymphocyt
obtain
centrifug
g
min
resuspend
medium
supplement
fb
uml
penicillin
mgml
streptomycin
case
lymphocyt
sampl
store
process
immunostain
flow
cytometri
lymphocyt
subset
determin
doubl
stain
panel
antimous
monoclon
antibodi
analyz
flow
cytometri
phenotyp
lymphocyt
subset
identifi
stain
phycoerythrin
pe
conjug
biolegend
fluorescein
isothiocyan
fitc
conjug
biolegend
fitcconjug
biolegend
peconjug
biolegend
peconjug
biolegend
cell
incub
min
mixtur
fitcand
peconjug
mous
monoclon
antibodi
dilut
pb
contain
vv
fb
dark
centrifug
g
min
cell
wash
time
pb
fix
pb
contain
paraformaldehyd
store
dark
analysi
flow
cytomet
facscanto
bd
bioscienc
san
jose
ca
statist
analysi
differ
surviv
rate
treat
control
group
assess
chisquar
test
use
spss
window
ibm
armonk
ny
studi
effect
igi
intestin
inflamm
model
level
signific
collect
data
evalu
use
oneway
analysi
varianc
studentneumankeul
posthoc
test
differ
consid
signific
p
b
mice
receiv
typhimurium
challeng
show
typic
clinic
sign
infect
includ
lethargi
inappet
piloerect
within
h
challeng
wherea
control
mice
exhibit
symptom
typhimurium
infect
surviv
rate
control
mice
challengeduntr
mice
well
challeng
mice
treat
nonspecif
specif
igi
respect
day
postchalleng
fig
mice
treat
specif
igi
show
signific
differ
surviv
rate
compar
posit
control
group
p
b
surviv
rate
challengeduntr
mice
mice
remain
treatment
end
experi
therefor
keep
sampl
size
equal
mice
randomli
select
group
subsequ
analysi
mice
specif
igytr
group
control
group
similar
bodi
weight
gain
significantli
higher
p
b
challeng
untreat
treat
nonspecif
igi
fig
find
indic
oral
administr
specif
igi
abl
provid
effect
passiv
protect
typhimurium
challeng
mice
histopatholog
featur
jejunum
mice
examin
shown
fig
infect
mice
mucos
damag
intestin
inflamm
observ
challeng
jejunum
challengeduntr
mice
sever
submucos
edema
increas
mononuclear
inflammatori
cell
infiltr
lamina
propria
epitheli
damag
fig
treatment
nonspecif
igi
specif
igi
allevi
damag
inflict
typhimurium
challeng
specif
igi
treatment
effect
reduc
jejunum
ulcer
transmur
inflamm
edema
greater
extent
treatment
fig
h
statist
analysi
intestin
patholog
injuri
score
standard
also
show
protect
function
igi
fig
jejunum
specif
igi
nonspecif
igi
group
lower
inflammatori
score
compar
challengeduntr
group
indic
attenu
inflammatori
respons
express
level
proinflammatori
cytokin
well
antiinflammatori
cytokin
measur
intestin
mucosa
typhimurium
challeng
increas
express
level
p
b
fig
b
nonspecif
igi
alter
effect
typhimurium
reduc
express
p
b
specif
igi
prevent
typhimuriuminduc
increas
p
b
addit
result
indic
infect
decreas
express
antiinflammatori
cytokin
fig
nonspecif
igi
affect
mucos
express
challeng
mice
howev
specif
igi
significantli
increas
express
p
b
lymphocyt
popul
jejunum
examin
fig
brown
area
show
differ
lymphocyt
popul
quantif
lymphocyt
popul
shown
fig
typhimurium
challeng
significantli
p
b
increas
number
lymphocyt
lamina
propria
compart
fig
nonspecif
igi
specif
igi
reduc
effect
typhimurium
compart
p
b
fig
lymphocyt
compos
main
subpopul
name
lymphocyt
also
call
helper
lymphocyt
lymphocyt
suppressorcytotox
lymphocyt
number
helper
lymphocyt
typhimuriumchalleng
mice
higher
control
mice
p
b
fig
nonspecif
igi
specif
igi
attenu
increas
number
helper
lymphocyt
induc
typhimurium
challeng
p
b
addit
suppressorcytotox
lymphocyt
observ
untreat
typhimuriumchalleng
group
control
group
number
suppressorcytotox
lymphocyt
decreas
nonspecif
igi
specif
igi
p
b
number
lymphocyt
untreat
typhimuriumchalleng
group
increas
compar
control
group
p
b
administr
nonspecif
igi
specif
igi
attenu
increas
number
lymphocyt
occur
result
typhimurium
challeng
p
b
typhimurium
challeng
modifi
percentag
cell
intestin
intraepitheli
lymphocyt
popul
particular
percentag
intestin
intraepitheli
lymphocyt
increas
control
mice
untreat
mice
challeng
typhimurium
p
b
fig
typhimurium
administr
also
increas
percentag
cell
compar
control
mice
intestin
intraepitheli
lymphocyt
p
b
percentag
cell
significantli
decreas
mice
treat
specif
igi
p
b
nonspecif
igi
effect
lymphocyt
percentag
lamina
propria
compart
percentag
cell
significantli
increas
typhimurium
challeng
p
b
fig
percentag
activ
lymphocyt
mainli
modifi
specif
igi
attenu
effect
typhimurium
challeng
percentag
cell
compart
p
b
neither
specif
igi
nonspecif
igi
modifi
typhimurium
effect
number
cell
peyer
patch
typhimurium
administr
increas
percentag
total
lymphocyt
cell
compar
control
mice
p
b
fig
addit
typhimurium
caus
increas
number
peyer
patchesactiv
lymphocyt
mainli
compar
control
mice
p
b
specif
igi
diminish
effect
typhimurium
number
total
lymphocyt
cell
p
b
cell
tend
decreas
specif
igi
treatment
effect
nonspecif
igi
observ
variou
lymphocyt
popul
sinc
origin
describ
streptomycinpretr
mous
model
increasingli
use
intestin
model
infect
investig
hostpathogen
interact
underli
typhimurium
induc
gastroenter
ie
typhliti
coliti
studi
establish
streptomycinpretr
mous
model
intestin
inflamm
induc
typhimurium
similar
establish
barthel
et
al
studi
mice
pretreat
streptomycin
h
infect
modifi
murin
intestin
flora
thu
allow
typhimurium
evok
inflamm
small
intestin
conduct
analysi
jejunum
monitor
intestin
infect
addit
chose
mice
wean
mucos
immun
system
still
immatur
time
suscept
infect
model
streptomycinpretr
mice
exhibit
intestin
inflamm
indic
histopatholog
lesion
develop
typic
clinic
sign
suggest
model
function
instrument
test
efficaci
igi
treat
enter
salmonellosi
caus
typhimurium
protect
confer
oral
administr
igi
confirm
day
challeng
surviv
rate
control
mice
challengeduntr
mice
challeng
mice
treat
nonspecif
specif
igi
respect
day
postchalleng
accord
find
yokoyama
et
al
found
igi
antibodi
specif
outer
membran
protein
lipopolysaccharid
flagella
control
salmonellosi
oral
administr
mice
follow
challeng
typhimurium
confirm
find
histopatholog
analysi
show
microvillu
damag
evid
inflamm
cross
section
jejunum
untreat
challeng
mice
treatment
infect
mice
specif
igi
allevi
gut
damag
inflamm
observ
clearli
indic
igi
provid
effect
protect
typhimuriuminduc
intestin
infect
also
investig
effect
igi
immun
system
typhimurium
infect
order
better
understand
mechan
igi
confer
protect
previou
studi
shown
igi
associ
immun
system
newborn
bovin
fish
immunomodulatori
function
infect
fulli
character
present
studi
found
import
immunomodulatori
role
igi
cytokin
gene
express
lymphocyt
popul
galt
mice
challeng
typhimurium
number
microorgan
develop
capac
invad
cell
host
evok
inflammatori
respons
previou
report
shown
cell
play
import
role
infect
intracellular
pathogen
typhimurium
activ
antimicrobi
activ
macrophag
via
secret
upregul
proinflammatori
cytokin
import
curb
extent
infect
howev
excess
proinflammatori
respons
also
known
detriment
host
proinflammatori
respons
control
order
maintain
balanc
immun
system
present
studi
igi
observ
regul
respons
infect
challeng
mice
treat
specif
igi
significantli
reduc
proinflammatori
respons
express
gene
proinflammatori
cytokin
especi
lower
challeng
mice
treat
specif
igi
compar
untreat
infect
mice
observ
suggest
import
role
igi
downregul
cytokin
express
addit
stimul
mucos
galt
induc
typhimurium
drive
mucos
immun
respons
toward
type
cellular
immun
respons
character
product
larg
amount
cell
clearli
shown
cell
play
import
role
control
typhimurium
infect
cell
particular
involv
studi
typhimurium
induc
signific
mobil
lymphocyt
includ
cell
epithelium
lamina
propria
reflect
inflammatori
process
prevent
specif
igi
effect
consist
observ
galt
popul
epithelium
lamina
propria
indic
two
mucos
compart
may
target
regulatori
effect
igi
studi
suggest
involv
protect
rather
reflect
sever
diseas
low
level
shown
increas
sever
crohn
diseas
patient
compar
high
level
result
show
antiinflammatori
cytokin
decreas
infect
alon
show
increas
anim
treat
specif
igi
suggest
level
increas
phase
diseas
resolut
presenc
specif
igi
express
increas
regulatori
cell
mainli
cell
produc
chang
challeng
mice
treat
specif
igi
might
explain
fact
produc
varieti
cell
addit
cell
intestin
intraepitheli
lymphocyt
play
critic
role
gener
complex
immunoregulatori
network
typhimurium
infect
ensu
host
respons
major
intestin
intraepitheli
lymphocyt
lymphocyt
lymphocyt
lie
mucos
epitheli
surfac
found
associ
repair
damag
epitheli
cell
protect
immun
respons
form
first
line
defens
pathogen
cell
effect
provid
immun
typhimurium
present
experi
found
typhimurium
significantli
increas
product
cell
particularli
cell
stimul
strong
cellular
immun
typhimurium
infect
reflect
overstimul
immun
system
result
consist
observ
typhimurium
promot
expans
intestin
intraepitheli
lymphocyt
particularli
cell
increas
number
cell
activ
prevent
specif
igi
indic
specif
igi
could
weaken
cellular
immun
activ
possibl
recogn
bind
typhimurium
allevi
immun
stress
addit
effect
typhimurium
challeng
cell
intestin
intraepitheli
lymphocyt
modest
cell
small
subset
mucos
compart
lamina
propria
one
constitu
galt
involv
effector
phase
intestin
immun
respons
present
studi
observ
typhimurium
infect
stimul
product
cell
compart
suggest
overstimul
immun
system
specif
igi
prevent
typhimuriuminduc
increas
compart
reduc
immun
activ
lamina
propria
peyer
patch
induct
site
mucos
immun
respons
oral
infect
colon
small
intestin
typhimurium
penetr
epitheli
barrier
invas
cell
particular
less
effici
transport
via
cell
possibl
penetr
enterocyt
penetr
epitheli
barrier
typhimurium
shown
colon
peyer
patch
bacteria
move
mesenter
lymph
node
spread
via
effer
lymph
circulatori
system
lead
system
infect
peyer
patch
often
use
evalu
lymphocyt
associ
respons
local
lymphoid
tissu
previou
studi
present
studi
typhimuriuminduc
increas
percentag
lymphocyt
peyer
patch
suggest
cytotox
lymphocyt
respons
typhimuriuminduc
intestin
immun
activ
specif
igi
attenu
increas
lymphocyt
induc
typhimurium
challeng
mechan
igi
inhibit
lymphocyt
prolifer
known
salmonella
compon
express
bacteri
surfac
lipopolysaccharid
outer
membran
protein
crucial
virul
factor
igi
found
attenu
inflammatori
respons
via
regul
tlymphocyt
function
possibl
recogn
bind
typhimurium
bind
may
block
surfac
structur
bacteria
neutral
toxic
compon
lipopolysaccharid
well
prevent
adhes
bacteria
target
surfac
eg
epitheli
cell
cell
host
penetr
bacteria
deeper
tissu
addit
nonspecif
igi
effect
extent
prevent
typhimuriuminduc
increas
proinflammatori
cytokin
lymphocyt
galt
sever
paper
report
nonspecif
igi
improv
phagocytosi
e
coli
staphylococcu
aureu
nonspecif
igi
could
weaken
cellular
immun
activ
possibl
phagocytosi
opson
allevi
immun
stress
howev
might
good
avenu
futur
research
studi
focus
effect
igi
intestin
mucos
immun
respons
infect
gut
main
site
igi
activ
intestin
pathogen
mucos
immun
system
effect
igi
product
cytokin
lymphocyt
spleen
system
tissu
local
lymphoid
tissu
mesenter
lymph
node
well
product
cytokin
peyer
patch
studi
would
product
avenu
futur
research
present
result
encourag
us
continu
evalu
immunomodulatori
effect
igi
detail
conclus
found
specif
igi
effect
allevi
typhimuriuminflict
damag
jejunum
play
import
role
limit
consequ
intestin
inflamm
induc
typhimurium
studi
highlight
interact
igi
intestin
mucos
immun
respons
infect
specif
igi
posit
modul
intestin
mucos
immun
respons
organ
diffus
galt
includ
reduc
lymphocyt
popul
peyer
patch
epithelium
lamina
propria
thu
protect
site
possibl
excess
activ
evok
typhimurium
effect
accompani
attenu
increas
proinflammatori
cytokin
intestin
mucosa
whether
igi
function
tissu
remain
determin
